UA
53
3
NVDA
56
5
CPB
32
-2
INTC
36
3
COF
42
3
THC
41
-2
MMM
42
5
CAT
44
2
DVA
56
2
CNP
49
2
AVY
39
2
WDC
41
4
A
48
4
AXP
62
5
FOXA
67
3
ILMN
38
7
EXR
30
6
RSG
47
2
DHI
35
4
PM
56
6
UA
53
3
NVDA
56
5
CPB
32
-2
INTC
36
3
COF
42
3
THC
41
-2
MMM
42
5
CAT
44
2
DVA
56
2
CNP
49
2
AVY
39
2
WDC
41
4
A
48
4
AXP
62
5
FOXA
67
3
ILMN
38
7
EXR
30
6
RSG
47
2
DHI
35
4
PM
56
6
Financhill
Back

Bio-Techne Vs. Perspective Therapeutics Industry Stock Comparison

Sell
32

TECH
Bio-Techne

Last Price:
$73.83
Seasonality Move:
3.21%
Sell
25

CATX
Perspective Therapeutics

Last Price:
$3.50
Seasonality Move:
43.39%
Sell
32
Bio-Techne (TECH) is a Sell

Is Bio-Techne a Buy, Sell or Hold?

  • The current Bio-Techne [TECH] share price is $73.79. The Score for TECH is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • TECH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.51. The Score for CATX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TECH Stock Price Chart

What is Bio-Techne's stock price today?

  • The Bio-Techne share price today is $73.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TECH is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TECH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 51.14 Buy
Chaikin Money Flow: 551154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.48 - 76.22) Sell
Bollinger Bands (100): (70.99 - 76.45) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 37.48 Sell
Chaikin Money Flow: 704863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.07 - 3.87) Buy
Bollinger Bands (100): (5.54 - 14.76) Sell

TECH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.69 Buy
20-day SMA: 74.05 Sell
50-day SMA: 73.43 Buy
200-day SMA: 73.92 Sell
8-day EMA: 72.83 Buy
20-day EMA: 73.38 Buy
50-day EMA: 73.65 Buy
200-day EMA: 73.85 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.24 Buy
20-day SMA: 3.32 Buy
50-day SMA: 6.48 Sell
200-day SMA: 11.89 Sell
8-day EMA: 3.27 Buy
20-day EMA: 3.68 Sell
50-day EMA: 5.95 Sell
200-day EMA: 9.5 Sell

Bio-Techne Earnings Growth & TECH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.30 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.35 per share.

Bio-Techne Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):